Cenegermin
Cenegermin (pronunciation: sen-eh-jer-min) is a recombinant form of human nerve growth factor. It is used in the treatment of neurotrophic keratitis, a rare degenerative disease of the cornea.
Etymology
The term "Cenegermin" is derived from the Latin words "ceno" meaning new and "germin" meaning growth, referring to its role in promoting nerve growth.
Usage
Cenegermin is used in the treatment of neurotrophic keratitis, a rare degenerative disease of the cornea. It works by promoting corneal healing, reducing the risk of corneal melting, perforation, and loss of vision.
Pharmacology
Cenegermin acts as a nerve growth factor (NGF), which is a protein necessary for the growth, maintenance, and survival of certain nerve cells. It works by binding to specific receptors on the surface of cells, triggering a series of reactions that lead to cell growth and survival.
Side Effects
Common side effects of Cenegermin include eye pain, ocular hyperemia (increased blood flow to the eye), eye inflammation, and increased lacrimation (tearing).
Related Terms
See Also
External links
- Medical encyclopedia article on Cenegermin
- Wikipedia's article - Cenegermin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski